Francesca’s Holdings Corp (NASDAQ:FRAN) – Research analysts at B. Riley cut their Q2 2019 earnings estimates for shares of Francesca’s in a note issued to investors on Wednesday, June 6th. B. Riley analyst S. Anderson now anticipates that the specialty retailer will earn $0.04 per share for the quarter, down from their prior estimate of $0.25. B. Riley currently has a “Hold” rating and a $6.00 target price on the stock. B. Riley also issued estimates for Francesca’s’ Q3 2019 earnings at $0.25 EPS and FY2019 earnings at $0.58 EPS.
Get Francesca’s alerts:
Other research analysts also recently issued research reports about the company. ValuEngine upgraded Francesca’s from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. TheStreet upgraded Francesca’s from a “d+” rating to a “c-” rating in a research note on Friday, June 1st. Zacks Investment Research upgraded Francesca’s from a “sell” rating to a “hold” rating in a research note on Wednesday, May 30th. Jefferies Group restated a “hold” rating and issued a $5.00 target price on shares of Francesca’s in a research note on Tuesday, March 27th. Finally, William Blair restated a “market perform” rating on shares of Francesca’s in a research note on Tuesday, March 27th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the stock. Francesca’s has a consensus rating of “Hold” and a consensus target price of $6.75.
Top Heal Care Stocks To Own For 2021: Chipotle Mexican Grill Inc.(CMG)
Chipotle Mexican Grill, Inc. develops and operates fast-casual, fresh Mexican food restaurants in the United States, Canada, and England. Its restaurants primarily offer burritos, tacos, burrito bowls, and salads. As of December 31, 2011, it operated 1,230 restaurants, which includes 1 ShopHouse Southeast Asian Kitchen. Chipotle Mexican Grill, Inc. was founded in 1993 and is based in Denver, Colorado.
- [By Motley Fool Transcribers]
Chipotle Mexican Grill Inc (NYSE:CMG)Q12019 Earnings CallApril 24, 2019, 4:30 p.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Adam Levine-Weinberg]
I have been bullish about Chipotle Mexican Grill (NYSE:CMG) for several years, believing that Chipotle would eventually recover from its food safety problems. During 2018 in particular, the fast-casual pioneer made a lot of progress in accelerating its comp sales growth and returning to margin expansion (excluding one-time costs).
- [By Logan Wallace]
NumerixS Investment Technologies Inc trimmed its position in shares of Chipotle Mexican Grill, Inc. (NYSE:CMG) by 88.9% in the 4th quarter, HoldingsChannel reports. The fund owned 500 shares of the restaurant operator’s stock after selling 4,000 shares during the quarter. NumerixS Investment Technologies Inc’s holdings in Chipotle Mexican Grill were worth $212,000 as of its most recent SEC filing.
Top Heal Care Stocks To Own For 2021: Daxor Corporation(DXR)
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
- [By Lisa Levin]
Check out these big penny stock gainers and losers
Verastem, Inc. (NASDAQ: VSTM) fell 9.7 percent to $4.73 in pre-market trading after announcing a $35 million common stock offering.
Evolus, Inc. (NASDAQ: EOLS) shares fell 8 percent to $13.48 in pre-market trading ahead of regulatory update at 8:30 a.m. ET.
XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) fell 6.5 percent to $2.01 in pre-market trading after climbing 10.50 percent on Tuesday.
Purple Innovation, Inc. (NASDAQ: PRPL) shares fell 5.8 percent to $9.36 in pre-market trading after reporting Q1 results.
Blink Charging Co. (NASDAQ: BLNK) fell 5.7 percent to $5.15 in pre-market trading after declining 5.04 percent on Tuesday.
RYB Education, Inc. (NYSE: RYB) shares fell 5 percent to $16.39 in pre-market trading following Q1 results.
Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares fell 4.4 percent to $4.30 in pre-market trading after rising 40.62 percent on Tuesday.
Arbor Realty Trust, Inc. (NYSE: ABR) fell 4.4 percent to $8.92 in pre-market trading after announcing a 5.5 million share common stock offering.
Daxor Corporation (NYSE: DXR) fell 4.1 percent to $7.32 in pre-market trading.
Ormat Technologies, Inc. (NYSE: ORA) shares fell 3.8 percent to $51.03 in pre-market trading after the company announced plans to restate its Q2, Q3, Q4 and FY 2017 financial statements.
Canadian Solar Inc. (NASDAQ: CSIQ) fell 3.5 percent to $16.20 in pre-market trading after reporting Q1 results.
CELYAD SA/ADR (NASDAQ: CYAD) shares fell 3.3 percent to $29.70 in pre-market trading after the company reported launch of 1.8 million share offering
- [By Logan Wallace]
Daxor Co. (NYSEAMERICAN:DXR) saw a significant growth in short interest in the month of March. As of March 29th, there was short interest totalling 234,045 shares, a growth of 1,257.4% from the March 15th total of 17,242 shares. Based on an average daily trading volume, of 1,214,477 shares, the days-to-cover ratio is presently 0.2 days. Currently, 33.3% of the company’s shares are short sold.
Top Heal Care Stocks To Own For 2021: GlaxoSmithKline PLC(GSK)
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The companys wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The companys nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc has a collaboration agreements with Universit茅 de Sherbrooke and Pfizer Inc.; development agreement, and R and D collaboration with Propeller Health; and collaboration and license agreement with Idera pharmaceuticals, Inc. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.
- [By ]
GlaxoSmithKline (NYSE: GSK) has fought for its asthma drug Advair, including the patented inhaler, for a few years now. Now, however, it seems to be finally facing off against generic competition. Just a month ago, on February 8, GSK announced that it plans to make an “authorized generic” version of Advair available. This is likely in a response to the FDA approving the first generic version of Advair on January 30, and an attempt to save at least some of the $1.4 billion in annual sales.
- [By Ethan Ryder]
TRADEMARK VIOLATION NOTICE: “GlaxoSmithKline plc (GSK) Shares Bought by Usca Ria LLC” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/4196137/glaxosmithkline-plc-gsk-shares-bought-by-usca-ria-llc.html.
- [By Cory Renauer]
In stark contrast to Geron, Agenus is guilty of running more programs than it can afford.The company’s vaccine booster is a component of GlaxoSmithKline’s (NYSE:GSK) new shingles vaccine, Shingrix. Agenus was entitled to a single-digit percentage of blockbuster Shingrix sales, but it sold all rights to those royalties last year in return for $190 million up front.
- [By Cory Renauer]
If you haven’t looked at GlaxoSmithKline (NYSE:GSK) and Eli Lilly (NYSE:LLY) in several years, you probably wouldn’t recognize them today. Eli Lilly recently spun off its animal health segment, and Glaxo’s merging its consumer health business with Pfizer’s (NYSE:PFE).
Top Heal Care Stocks To Own For 2021: Rave Restaurant Group, Inc.(RAVE)
Rave Restaurant Group, Inc., together with its subsidiaries, operates and franchises pizza buffet, delivery/carry-out (delco), and express restaurants under the Pizza Inn trademark in the United States and internationally. It operates in two segments, Franchising and Food and Supply Distribution, and Company-Owned Restaurants. The companys buffet restaurants, which are located in free standing buildings or strip centers in retail developments that offer dine-in, carryout, and catering services, as well as delivery services. Its delco restaurants provide delivery and carryout services and are located in shopping centers or other in-line retail developments. The companys Express restaurants serve customers through various non-traditional points of sale and are located in convenience stores, food courts, college campuses, airport terminals, travel plazas, athletic facilities, or other commercial facilities. RAVE Restaurant Group, Inc. also operates and franchises fast casual restaurants under the Pie Five Pizza Company or Pie Five trademark. As of September 24, 2015, it owned, operated, and franchised approximately 300 Pie Five Pizza Co. and Pizza Inn restaurants. The company was formerly known as Pizza Inn Holdings, Inc. and changed its name to RAVE Restaurant Group, Inc. in January 2015. RAVE Restaurant Group, Inc. was founded in 1958 and is based in The Colony, Texas.
- [By Ethan Ryder]
Media coverage about Pizza Inn (NASDAQ:RAVE) has trended somewhat positive recently, according to Accern. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Pizza Inn earned a coverage optimism score of 0.06 on Accern’s scale. Accern also assigned news coverage about the restaurant operator an impact score of 44.1311226041984 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.